Skip to content

Vireo Growth Inc.

VREOD VREOF

CIK 0001771706 · Pharmaceutical Preparations · OTC, OTC

  • Goodness Growth Holdings, Inc. (until 2024-06-24)
  • Vireo Health International, Inc. (until 2021-05-14)
Revenue (TTM)
$270.42M
+170.4% YoY Q1 Mar 2026
Net Income (TTM)
−$68.03M
−143.2% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$0.10
+43.8% YoY Q1 Mar 2026
Gross Margin
47.9%
Q1 Mar 2026
Operating Margin
3.6%
Q1 Mar 2026
Net Margin
-25.2%
Q1 Mar 2026
Free Cash Flow (TTM)
−$9.48M
Q1 Mar 2026
Cash
$137.8M
Q1 Mar 2026
Total Debt
$58.21M
Q1 Mar 2026
Shares Outstanding
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Latest news

All news →

Recent filings